Trump health deal – The Milli Chronicle

NewsDesk Milli Chronicle November 6, 2025November 6, 2025 affordable healthcare, American health programs, diabetes care, drug pricing reform, Eli Lilly, GLP-1 medications, healthcare accessibility, injectable treatments, Medicaid access, Medicaid benefits, medical affordability, Medicare coverage, Medicare discounts, Novo Nordisk, obesity treatment, orforglipron, pharmaceutical innovation, prescription savings, public-private partnership, Trump health deal, TrumpRx program, U.S. drug market, U.S. healthcare reform, Wegovy, weight-loss drugs, weight-loss pills, Zepbound

U.S. Strikes Breakthrough Deal to Boost Access to Weight-Loss Drugs

A landmark public-private partnership aims to make life-changing obesity and diabetes treatments more affordable and accessible for millions across America.